The system will be going down for regular maintenance. Please save your work and logout.
Tixagevimab-cilgavimab (AZD7442) for the treatment of patients hospitalized with COVID-19 (DisCoVeRy): A phase 3, randomized, double-blind, placebo-controlled trial
Language
EN
Article de revue
This item was published in
Journal of Infection. 2024-02-16, vol. 88, n° 3, p. 106120

